XML 50 R11.htm IDEA: XBRL DOCUMENT v3.20.1
SEGMENT INFORMATION
 6 Months Ended
Mar. 31, 2020
SEGMENT INFORMATION  
SEGMENT INFORMATION

5.    SEGMENT INFORMATION

We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions.  Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to Consolidated Financial Statements in our annual report on Form 10-K for the fiscal year ended September 30, 2019.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

March 31,

 

March 31,

 

    

2020

    

2019

    

2020

    

2019

Revenue:

 

 

  

 

 

  

 

 

  

 

 

  

Service

 

$

15,191

 

$

8,131

 

$

27,333

 

$

15,866

Product

 

 

821

 

 

1,213

 

 

1,597

 

 

2,103

 

 

$

16,012

 

$

9,344

 

$

28,930

 

$

17,969

Operating Income (Loss)

 

 

  

 

 

  

 

 

  

 

 

  

Service

 

$

2,575

 

$

877

 

$

3,933

 

$

1,513

Product

 

 

(200)

 

 

30

 

 

(470)

 

 

(50)

Corporate

 

 

(2,570)

 

 

(1,355)

 

 

(4,678)

 

 

(1,870)

 

 

$

(195)

 

$

(449)

 

$

(1,215)

 

$

(408)

 

 

 

  

 

 

  

 

 

  

 

 

  

Interest expense

 

 

(392)

 

 

(122)

 

 

(703)

 

 

(248)

Other income

 

 

10

 

 

 3

 

 

12

 

 

 4

Loss before income taxes

 

$

(577)

 

$

(568)

 

$

(1,906)

 

$

(652)